APA استشهاد

Koyama, N., Tokura, Y., Münch, D., Sahl, H., Schneider, T., Shibagaki, Y., . . . Tomoda, H. (2012). The Nonantibiotic Small Molecule Cyslabdan Enhances the Potency of β-Lactams against MRSA by Inhibiting Pentaglycine Interpeptide Bridge Synthesis. Public Library of Science.

استشهاد بنمط شيكاغو

Koyama, Nobuhiro, Yuriko Tokura, Daniela Münch, Hans-Georg Sahl, Tanja Schneider, Yoshio Shibagaki, Haruo Ikeda, و Hiroshi Tomoda. The Nonantibiotic Small Molecule Cyslabdan Enhances the Potency of β-Lactams against MRSA By Inhibiting Pentaglycine Interpeptide Bridge Synthesis. Public Library of Science, 2012.

MLA استشهاد

Koyama, Nobuhiro, et al. The Nonantibiotic Small Molecule Cyslabdan Enhances the Potency of β-Lactams against MRSA By Inhibiting Pentaglycine Interpeptide Bridge Synthesis. Public Library of Science, 2012.

تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.